MEETINGS - European Health Policy Forum (Belgium) December 1997:
This article was originally published in Clinica
The 64th European Health Policy Forum will be held on December 11-12 in Leuven, Belgium. The meeting will cover topics including strategies and implementation of telemedicine; healthcare institutions joining the information highway; remote consultation in primary healthcare; and data warehousing. For more information contact the Centre for Health Services and Nursing Research in Belgium. Tel: +32 16 336978. Fax: +32 50 220541.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.